From: Clinical value of noninvasive lens advanced glycation end product detection in early screening and severity evaluation of patients with diabetic kidney disease
Group
P <
95% CI
Lower limit
Upper limit
Noninvasive lens AGE level
0.014
0.001
0.455
Cystatin C (mg/L)
0.068
0.131
1.077